Small-cap biotech investing fails most people for structural reasons, not for lack of discipline. Value arrives in blocks on scheduled dates, funding arrives through dilution, and the probabilities underneath every valuation model are contested by a factor of two.
The sinus microbiome is reshaping how we understand chronic sinusitis — from a single infection to a disturbed ecosystem. Here’s what the evidence supports, and what remains unproven.
An otolaryngologist’s guide to nose-to-brain drug delivery — how nasal sprays reach the brain, which treatments are already approved, and why an open nasal airway decides whether they work.
The FDA’s approval of tirzepatide for sleep apnea gave OSA its first-ever drug. Here’s what it treats, how it works, and the oral pill coming next.
What is the depression nasal spray? A concise, evidence-based look at esketamine (Spravato) — its mechanism, FDA-approved uses, trial results, and commercial rise.
Nodules, polyps, and cysts can all leave you hoarse — but they are not the same problem. Here is a clear vocal nodule vs polyp vs cyst guide to what causes each one, the symptoms to watch for, and which treatments actually work.
A 2026 study pitted four AI models against 100 doctors on AI ENT referral decisions. Diagnosis was a tie—so where did the models actually pull ahead?
How does an opera singer soar over a full orchestra with no microphone? The answer is the singer’s formant — one narrow band of sound near 3 kHz. Here is how it forms and why it matters in the clinic.
It began as a £1 pandemic favour and grew into a £330 million contract. Between the two, Palantir became embedded in the plumbing of the NHS — and a question the health service still cannot answer cleanly took hold: did the platform actually work, and at what cost to trust?
Does Ginkgo Biloba Work for tinnitus or memory? Marketing says yes, but independent trials tell a more cautious story. An ENT sorts the proven from the unproven — and the bleeding-risk caveats worth knowing.
